L-701252

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断

甘氨酸-NMDA 位点拮抗剂。

glycine-NMDA site antagonist(In Vivo):L-701252 (50 mg/kg; i.p.) provides a small non-significant protection.

——

L-701252 (50 mg/kg; i.p.) provides a small non-significant protection. Animal Model:3-Months Male Mongolian gerbils (60 g)Dosage:50 mg/kg Administration:i.p.Result:Provided a small non-significant protection.

L-701,252

Others

Other Targets

choline kinase alpha (ChoKα)

——

——

151057-13-5

263.68

C13H10ClNO3

>98% (HPLC)

In Vitro:?DMSO : 10 mg/mL (37.92 mM)

Oc1c(C(=O)C2CC2)c(=O)[nH]c2cc(Cl)ccc12

——

(-20℃)

With Ice Pack

≥ 2 years